Sg3 Management, LLC Seres Therapeutics, Inc. Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $151,200 - $212,160	-24,000 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$6.02 - $11.43 $172,774 - $328,041	-28,700 Reduced 54.46%	24,000 $200,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $129,402 - $535,620	23,700 Added 81.72%	52,700 $367,000
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $18,460 - $24,360	-1,000 Reduced 3.33%	29,000 $692,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $529,800 - $867,600	30,000 New	30,000 $618,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $86.9M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.